Find us on FaceBookFollow Us On Twitter
Home | Appointments | About The Center
Johns Hopkins Arthritis CenterJohns Hopkins Medicine
  • Arthritis Info
  • Patient Resources
  • Physician Resources
  • Arthritis News
  • Arthritis Research
  • Ask The Expert
ACR 2006 Highlights from Johns Hopkins University
Home > ACR 2006 Highlights > RA > TNF Antagonists

RA TNF Antagonists

Clifton Bingham, M.D. - Jon Giles, M.D.

Abstract 676: A Difference in Effectiveness Between Infliximab, Etanercept and Adalimumab in Patients with Rheumatoid Arthritis

Abstract 1235: Abilities to Develop Protective Antibodies to Pneumococcal and Influenza Vaccine are Maintained in Rheumatoid Arthritis (RA) Patients Treated with Adalimumab (Humira®)

Abstract 1311: Delay in Imaging Versus Clinical Response Provides Rationale for Prolonged Treatment with Anti-TNF in Early Rheumatoid Arthritis

Abstract 2123: One-Year Results of Golimumab Compared With Placebo in Patients With Active RA Despite Treatment With Methotrexate: A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial

footer line

  • Rheumatoid Arthritis
  • Treatment Strategies
  • TNF Antagonists
  • B-Cell Depletion
  • Other Agents
  • OA Clinical Aspects
  • Juvenile RA / Pediatric Rheumatology
  • Systemic Lupus Erythematosus
  • Vasculitis
  • Scleroderma
  • Fibromyalgia
  • Spondyloarthropathies
  • Myositis
  • Pregnancy in AutoImmune Disease
  • Non-Pharmacologic Management
  • Basic Science
  • Epidemiology
  • Psychosocial

Signup For Our Email Newsletter

Sitemap | Copyright |Privacy Policy | RSS |Contact Us | Johns Hopkins Rheumatology